Quinn Opportunity Partners LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 95 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$214,000
-36.9%
52,876
-32.6%
0.01%
-65.9%
Q3 2019$339,000
+24.2%
78,438
+14.6%
0.04%
+20.6%
Q2 2019$273,000
-25.6%
68,4380.0%0.03%
-32.0%
Q1 2019$367,000
-17.5%
68,438
-21.1%
0.05%
-19.4%
Q4 2018$445,000
-32.0%
86,722
+28.6%
0.06%
-33.3%
Q3 2018$654,000
+11.6%
67,438
+17.4%
0.09%
+19.2%
Q2 2018$586,000
-21.6%
57,4380.0%0.08%
-18.8%
Q1 2018$747,00057,4380.10%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,387,172$6,537,0001.72%
Worth Venture Partners, LLC 969,698$2,366,0001.39%
Omega Fund Management, LLC 1,971,241$3,804,0001.21%
Telemetry Investments, L.L.C. 495,000$955,0001.13%
CM Management, LLC 350,000$676,0000.72%
Bruce & Co., Inc. 1,557,312$3,005,0000.71%
Trellus Management Company, LLC 295,000$569,0000.69%
Abingworth LLP 1,041,131$1,999,0000.64%
1492 Capital Management LLC 489,376$944,0000.62%
GENERAL AMERICAN INVESTORS CO INC 1,752,470$3,382,0000.34%
View complete list of PARATEK PHARMACEUTICALS INC shareholders